These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 9229389)
1. Kinetics and mechanism of effector focus formation in the lungs of mice vaccinated with irradiated cercariae of Schistosoma mansoni. Smythies LE; Betts C; Coulson PS; Dowling MA; Wilson RA Parasite Immunol; 1996 Jul; 18(7):359-69. PubMed ID: 9229389 [TBL] [Abstract][Full Text] [Related]
2. T cell-derived cytokines associated with pulmonary immune mechanisms in mice vaccinated with irradiated cercariae of Schistosoma mansoni. Smythies LE; Pemberton RM; Coulson PS; Mountford AP; Wilson RA J Immunol; 1992 Mar; 148(5):1512-8. PubMed ID: 1538133 [TBL] [Abstract][Full Text] [Related]
3. Impaired immunity and altered pulmonary responses in mice with a disrupted interferon-gamma receptor gene exposed to the irradiated Schistosoma mansoni vaccine. Wilson RA; Coulson PS; Betts C; Dowling MA; Smythies LE Immunology; 1996 Feb; 87(2):275-82. PubMed ID: 8698391 [TBL] [Abstract][Full Text] [Related]
4. T cell derived cytokines in lung-phase immunity to Schistosoma mansoni. Wilson RA Mem Inst Oswaldo Cruz; 1992; 87 Suppl 4():105-9. PubMed ID: 1343880 [TBL] [Abstract][Full Text] [Related]
5. Immunity to Schistosoma mansoni in mice vaccinated with irradiated cercariae: cytokine interactions in the pulmonary protective response. Smythies LE; Coulson PS; Wilson RA Ann Trop Med Parasitol; 1993 Dec; 87(6):653-7. PubMed ID: 8122929 [TBL] [Abstract][Full Text] [Related]
6. T-helper type-1-dominated lymph node responses induced in C57BL/6 mice by optimally irradiated cercariae of Schistosoma mansoni are down-regulated after challenge infection. Pemberton RM; Wilson RA Immunology; 1995 Feb; 84(2):310-6. PubMed ID: 7751008 [TBL] [Abstract][Full Text] [Related]
7. The generation of interferon-gamma-producing T lymphocytes in skin-draining lymph nodes, and their recruitment to the lungs, is associated with protective immunity to Schistosoma mansoni. Mountford AP; Coulson PS; Pemberton RM; Smythies LE; Wilson RA Immunology; 1992 Feb; 75(2):250-6. PubMed ID: 1532378 [TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibody to IFN-gamma modifies pulmonary inflammatory responses and abrogates immunity to Schistosoma mansoni in mice vaccinated with attenuated cercariae. Smythies LE; Coulson PS; Wilson RA J Immunol; 1992 Dec; 149(11):3654-8. PubMed ID: 1431135 [TBL] [Abstract][Full Text] [Related]
9. Antigens derived from lung-stage larvae of Schistosoma mansoni are efficient stimulators of proliferation and gamma interferon secretion by lymphocytes from mice vaccinated with attenuated larvae. Mountford AP; Harrop R; Wilson RA Infect Immun; 1995 May; 63(5):1980-6. PubMed ID: 7729911 [TBL] [Abstract][Full Text] [Related]
10. Endothelial cells are activated by cytokine treatment to kill an intravascular parasite, Schistosoma mansoni, through the production of nitric oxide. Oswald IP; Eltoum I; Wynn TA; Schwartz B; Caspar P; Paulin D; Sher A; James SL Proc Natl Acad Sci U S A; 1994 Feb; 91(3):999-1003. PubMed ID: 7508126 [TBL] [Abstract][Full Text] [Related]
11. Pulmonary leukocytic responses are linked to the acquired immunity of mice vaccinated with irradiated cercariae of Schistosoma mansoni. Aitken R; Coulson PS; Wilson RA J Immunol; 1988 May; 140(10):3573-9. PubMed ID: 3129495 [TBL] [Abstract][Full Text] [Related]
12. Recruitment of lymphocytes to the lung through vaccination enhances the immunity of mice exposed to irradiated schistosomes. Coulson PS; Wilson RA Infect Immun; 1997 Jan; 65(1):42-8. PubMed ID: 8975890 [TBL] [Abstract][Full Text] [Related]
13. Vaccination with irradiated cercariae of Schistosoma mansoni preferentially induced the accumulation of interferon-gamma producing T cells in the skin and skin draining lymph nodes of mice. Kumar P; Ramaswamy K Parasitol Int; 1999 Aug; 48(2):109-19. PubMed ID: 11269272 [TBL] [Abstract][Full Text] [Related]
14. Radiation-resistant acquired immunity of vaccinated mice to Schistosoma mansoni. Aitken R; Coulson PS; Dixon B; Wilson RA Am J Trop Med Hyg; 1987 Nov; 37(3):570-7. PubMed ID: 3120610 [TBL] [Abstract][Full Text] [Related]
15. Inducible nitric oxide synthase-deficient mice develop enhanced type 1 cytokine-associated cellular and humoral immune responses after vaccination with attenuated Schistosoma mansoni cercariae but display partially reduced resistance. James SL; Cheever AW; Caspar P; Wynn TA Infect Immun; 1998 Aug; 66(8):3510-8. PubMed ID: 9673227 [TBL] [Abstract][Full Text] [Related]
16. Nitric oxide produced in the lungs of mice immunized with the radiation-attenuated schistosome vaccine is not the major agent causing challenge parasite elimination. Coulson PS; Smythies LE; Betts C; Mabbott NA; Sternberg JM; Wei XG; Liew FY; Wilson RA Immunology; 1998 Jan; 93(1):55-63. PubMed ID: 9536119 [TBL] [Abstract][Full Text] [Related]
17. Th1 cytokine mRNA expression dominates in the skin-draining lymph nodes of C57BL/6 mice following vaccination with irradiated Schistosoma mansoni cercariae, but is down-regulated upon challenge infection. Betts CJ; Wilson RA Immunology; 1998 Jan; 93(1):49-54. PubMed ID: 9536118 [TBL] [Abstract][Full Text] [Related]
18. Studies with double cytokine-deficient mice reveal that highly polarized Th1- and Th2-type cytokine and antibody responses contribute equally to vaccine-induced immunity to Schistosoma mansoni. Hoffmann KF; James SL; Cheever AW; Wynn TA J Immunol; 1999 Jul; 163(2):927-38. PubMed ID: 10395689 [TBL] [Abstract][Full Text] [Related]
19. In the absence of CD154, administration of interleukin-12 restores Th1 responses but not protective immunity to Schistosoma mansoni. Hewitson JP; Hamblin PA; Mountford AP Infect Immun; 2007 Jul; 75(7):3539-47. PubMed ID: 17485453 [TBL] [Abstract][Full Text] [Related]
20. TNF is essential for the cell-mediated protective immunity induced by the radiation-attenuated schistosome vaccine. Street M; Coulson PS; Sadler C; Warnock LJ; McLaughlin D; Bluethmann H; Wilson RA J Immunol; 1999 Oct; 163(8):4489-94. PubMed ID: 10510391 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]